Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A 20-year comparison of definitive chemoradiation with 5-FU versus capecitabine in anal cancer patients treated at Stanford. Pumpalova, Y. S., Kozak, M. M., von Eyben, R., Fisher, G. A., Kunz, P. L., Chang, D., Haraldsdottir, S. AMER SOC CLINICAL ONCOLOGY. 2018
View details for DOI 10.1200/JCO.2018.36.4_suppl.710
View details for Web of Science ID 000436174100686